RFG Advisory LLC Has $853,000 Holdings in Colgate-Palmolive (NYSE:CL)

RFG Advisory LLC increased its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 85.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 9,104 shares of the company's stock after buying an additional 4,199 shares during the quarter. RFG Advisory LLC's holdings in Colgate-Palmolive were worth $853,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in CL. Brighton Jones LLC raised its stake in Colgate-Palmolive by 4.4% during the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock worth $962,000 after buying an additional 450 shares during the period. Sargent Investment Group LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $209,000. Bernard Wealth Management Corp. acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $36,000. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Colgate-Palmolive by 20.1% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 157,811 shares of the company's stock valued at $14,402,000 after purchasing an additional 26,382 shares during the period. Finally, Choreo LLC raised its stake in shares of Colgate-Palmolive by 17.9% in the 4th quarter. Choreo LLC now owns 27,563 shares of the company's stock valued at $2,503,000 after purchasing an additional 4,190 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Barclays dropped their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday, April 11th. Wells Fargo & Company lifted their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research note on Wednesday, April 2nd. UBS Group lifted their price target on Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a research note on Thursday, April 17th. Piper Sandler dropped their price target on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research note on Monday, March 31st. Finally, Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $102.12.

Colgate-Palmolive Trading Down 0.2%

Colgate-Palmolive stock opened at $90.04 on Friday. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock has a market capitalization of $72.97 billion, a P/E ratio of 25.58, a PEG ratio of 4.20 and a beta of 0.38. The stock has a 50-day simple moving average of $91.84 and a 200 day simple moving average of $91.21.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The business had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. During the same quarter last year, the company posted $0.86 earnings per share. Colgate-Palmolive's quarterly revenue was down 3.0% on a year-over-year basis. Analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive announced that its Board of Directors has initiated a share repurchase program on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to buy up to 6.8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's leadership believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 15th. Investors of record on Thursday, April 17th were issued a dividend of $0.52 per share. The ex-dividend date was Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.31%. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.76%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.